Drug
Etravirine
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Eyelid Ptosis | 107 | 50.4 | 51.6 | signal |
| 2 | Drug Resistance | 266 | 49.6 | 52.7 | signal |
| 3 | Anhedonia | 219 | 39.5 | 41.5 | signal |
| 4 | Economic Problem | 84 | 26.0 | 26.5 | signal |
| 5 | Osteopenia | 82 | 25.6 | 26.1 | signal |
| 6 | Diplopia | 101 | 18.5 | 18.9 | signal |
| 7 | Osteoporosis | 126 | 14.6 | 15.0 | signal |
| 8 | Nephropathy | 28 | 14.2 | 14.3 | signal |
| 9 | Premature Baby | 87 | 13.7 | 14.0 | signal |
| 10 | End Stage Renal Disease | 52 | 13.4 | 13.6 | signal |
| 11 | Bone Density Decreased | 85 | 12.8 | 13.0 | signal |
| 12 | Blood Iron Decreased | 31 | 12.5 | 12.6 | signal |
| 13 | Chronic Kidney Disease | 192 | 11.9 | 12.4 | signal |
| 14 | Drug Level Increased | 41 | 11.8 | 11.9 | signal |
| 15 | Treatment Failure | 203 | 11.8 | 12.3 | signal |
| 16 | Hepatitis C | 29 | 11.3 | 11.4 | signal |
| 17 | Multiple Fractures | 37 | 10.6 | 10.7 | signal |
| 18 | Decreased Activity | 22 | 9.8 | 9.8 | signal |
| 19 | Foetal Exposure During Pregnancy | 166 | 9.7 | 10.0 | signal |
| 20 | Emotional Distress | 243 | 9.5 | 10.0 | signal |
| 21 | Hypercholesterolaemia | 19 | 9.4 | 9.5 | signal |
| 22 | Drug Level Decreased | 20 | 9.3 | 9.3 | signal |
| 23 | Nephropathy Toxic | 21 | 9.0 | 9.0 | signal |
| 24 | Cholestasis | 35 | 8.7 | 8.8 | signal |
| 25 | Proteinuria | 34 | 8.6 | 8.6 | signal |
| 26 | Treatment Noncompliance | 97 | 8.5 | 8.6 | signal |
| 27 | Bone Loss | 27 | 8.4 | 8.5 | signal |
| 28 | Drug Interaction | 281 | 8.4 | 8.9 | signal |
| 29 | Hepatic Cirrhosis | 33 | 8.4 | 8.4 | signal |
| 30 | Exposure During Pregnancy | 109 | 8.3 | 8.5 | signal |
| 31 | Premature Delivery | 28 | 8.3 | 8.4 | signal |
| 32 | Glomerular Filtration Rate Decreased | 21 | 8.2 | 8.3 | signal |
| 33 | Hepatic Steatosis | 32 | 8.2 | 8.2 | signal |
| 34 | Dermatitis Allergic | 21 | 8.0 | 8.0 | signal |
| 35 | Osteonecrosis | 55 | 7.9 | 8.0 | signal |
| 36 | Quality Of Life Decreased | 22 | 7.8 | 7.8 | signal |
| 37 | Hepatic Encephalopathy | 15 | 7.6 | 7.6 | signal |
| 38 | Hyperlipidaemia | 19 | 7.5 | 7.6 | signal |
| 39 | Toxic Skin Eruption | 16 | 7.5 | 7.5 | signal |
| 40 | Hyperbilirubinaemia | 16 | 7.4 | 7.4 | signal |
| 41 | Abortion Spontaneous | 61 | 7.2 | 7.3 | signal |
| 42 | Tooth Loss | 29 | 6.6 | 6.6 | signal |
| 43 | Vitamin D Deficiency | 13 | 6.3 | 6.3 | signal |
| 44 | Hepatomegaly | 13 | 6.3 | 6.3 | signal |
| 45 | Blood Creatine Phosphokinase Increased | 38 | 6.2 | 6.2 | signal |
| 46 | Neurotoxicity | 22 | 6.0 | 6.0 | signal |
| 47 | Foot Fracture | 24 | 6.0 | 6.0 | signal |
| 48 | Hepatitis | 32 | 5.9 | 6.0 | signal |
| 49 | Pancytopenia | 69 | 5.9 | 6.0 | signal |
| 50 | Blood Creatinine Increased | 81 | 5.9 | 6.0 | signal |
| 51 | Renal Failure | 165 | 5.9 | 6.0 | signal |
| 52 | Renal Tubular Necrosis | 12 | 5.8 | 5.8 | signal |
| 53 | Hepatocellular Injury | 17 | 5.7 | 5.7 | signal |
| 54 | Carpal Tunnel Syndrome | 16 | 5.4 | 5.4 | signal |
| 55 | Choking | 22 | 5.4 | 5.4 | signal |
| 56 | Rash Maculo-papular | 25 | 5.4 | 5.4 | signal |
| 57 | Stevens-johnson Syndrome | 25 | 5.3 | 5.4 | signal |
| 58 | Renal Failure Acute | 48 | 5.3 | 5.3 | signal |
| 59 | Maternal Exposure During Pregnancy | 98 | 5.3 | 5.4 | signal |
| 60 | Splenomegaly | 13 | 5.3 | 5.3 | signal |
| 61 | Renal Impairment | 92 | 5.2 | 5.3 | signal |
| 62 | Drug Dispensing Error | 17 | 5.2 | 5.2 | signal |
| 63 | Abortion Induced | 10 | 5.0 | 5.0 | signal |
| 64 | Skeletal Injury | 11 | 5.0 | 5.0 | signal |
| 65 | Drug Exposure During Pregnancy | 36 | 5.0 | 5.0 | signal |
| 66 | Renal Pain | 11 | 4.9 | 5.0 | signal |
| 67 | Hepatotoxicity | 23 | 4.9 | 4.9 | signal |
| 68 | Drug-induced Liver Injury | 32 | 4.9 | 5.0 | signal |
| 69 | Pancreatitis Acute | 23 | 4.9 | 4.9 | signal |
| 70 | Transaminases Increased | 22 | 4.7 | 4.7 | signal |
| 71 | Musculoskeletal Discomfort | 17 | 4.7 | 4.7 | signal |
| 72 | Hepatic Cytolysis | 12 | 4.7 | 4.7 | signal |
| 73 | Multi-organ Failure | 17 | 4.6 | 4.6 | signal |
| 74 | Immunodeficiency | 14 | 4.5 | 4.5 | signal |
| 75 | Polyneuropathy | 11 | 4.4 | 4.4 | signal |
| 76 | Adrenal Insufficiency | 11 | 4.4 | 4.4 | signal |
| 77 | Wrist Fracture | 11 | 4.4 | 4.4 | signal |
| 78 | Blood Triglycerides Increased | 16 | 4.3 | 4.3 | signal |
| 79 | Pneumocystis Jirovecii Pneumonia | 9 | 4.3 | 4.3 | signal |
| 80 | Hepatic Failure | 27 | 4.2 | 4.3 | signal |
| 81 | Anxiety | 247 | 4.1 | 4.3 | signal |
| 82 | Haematotoxicity | 8 | 4.1 | 4.1 | signal |
| 83 | Loss Of Personal Independence In Daily Activities | 41 | 4.1 | 4.1 | signal |
| 84 | Intervertebral Disc Degeneration | 8 | 4.1 | 4.1 | signal |
| 85 | Anaemia | 164 | 4.1 | 4.2 | signal |
| 86 | Eosinophilia | 15 | 4.1 | 4.1 | signal |
| 87 | Product Physical Issue | 17 | 4.0 | 4.1 | signal |
| 88 | Acute Respiratory Distress Syndrome | 15 | 4.0 | 4.0 | signal |
| 89 | Lymphadenopathy | 30 | 4.0 | 4.0 | signal |
| 90 | Acute Kidney Injury | 128 | 4.0 | 4.1 | signal |
| 91 | Drug Reaction With Eosinophilia And Systemic Symptoms | 21 | 3.9 | 3.9 | signal |
| 92 | Rhabdomyolysis | 34 | 3.9 | 3.9 | signal |
| 93 | Encephalopathy | 20 | 3.9 | 3.9 | signal |
| 94 | Skin Lesion | 22 | 3.8 | 3.8 | signal |
| 95 | Liver Disorder | 35 | 3.7 | 3.8 | signal |
| 96 | Aspartate Aminotransferase Increased | 41 | 3.7 | 3.7 | signal |
| 97 | Face Oedema | 13 | 3.6 | 3.6 | signal |
| 98 | Tubulointerstitial Nephritis | 14 | 3.5 | 3.6 | signal |
| 99 | Acute Myocardial Infarction | 22 | 3.5 | 3.5 | signal |
| 100 | Squamous Cell Carcinoma | 7 | 3.5 | 3.5 | signal |
| 101 | Arteriosclerosis | 7 | 3.5 | 3.5 | signal |
| 102 | Nervous System Disorder | 23 | 3.5 | 3.5 | signal |
| 103 | Hip Arthroplasty | 11 | 3.4 | 3.4 | signal |
| 104 | Diabetes Mellitus | 55 | 3.4 | 3.4 | signal |
| 105 | Ascites | 21 | 3.4 | 3.4 | signal |
| 106 | Jaundice | 19 | 3.3 | 3.4 | signal |
| 107 | Agranulocytosis | 13 | 3.3 | 3.3 | signal |
| 108 | Blood Bilirubin Increased | 19 | 3.3 | 3.3 | signal |
| 109 | Renal Injury | 21 | 3.3 | 3.3 | signal |
| 110 | Paranoia | 12 | 3.3 | 3.3 | signal |
| 111 | Gastric Ulcer | 13 | 3.2 | 3.2 | signal |
| 112 | Bacteraemia | 8 | 3.2 | 3.2 | signal |
| 113 | Alanine Aminotransferase Increased | 41 | 3.2 | 3.2 | signal |
| 114 | Product Packaging Issue | 6 | 3.1 | 3.1 | signal |
| 115 | Neuropathy Peripheral | 61 | 3.1 | 3.1 | signal |
| 116 | Ankle Fracture | 10 | 3.1 | 3.1 | signal |
| 117 | Tooth Fracture | 7 | 3.0 | 3.0 | signal |
| 118 | Rib Fracture | 13 | 3.0 | 3.0 | signal |
| 119 | Lower Limb Fracture | 12 | 3.0 | 3.0 | signal |
| 120 | Wrong Technique In Drug Usage Process | 23 | 3.0 | 3.0 | signal |
| 121 | Myocarditis | 7 | 2.9 | 2.9 | signal |
| 122 | Hepatic Enzyme Increased | 42 | 2.9 | 3.0 | signal |
| 123 | Generalised Tonic-clonic Seizure | 10 | 2.9 | 2.9 | signal |
| 124 | Laboratory Test Abnormal | 18 | 2.9 | 2.9 | signal |
| 125 | Hyperkalaemia | 21 | 2.9 | 2.9 | signal |
| 126 | Incorrect Product Storage | 8 | 2.8 | 2.9 | signal |
| 127 | Acute Hepatic Failure | 8 | 2.8 | 2.8 | signal |
| 128 | Depression | 133 | 2.8 | 2.8 | signal |
| 129 | Dysstasia | 17 | 2.8 | 2.8 | signal |
| 130 | Dysuria | 21 | 2.7 | 2.7 | signal |
| 131 | Joint Dislocation | 6 | 2.7 | 2.7 | signal |
| 132 | Nephrolithiasis | 26 | 2.7 | 2.7 | signal |
| 133 | Drug Eruption | 10 | 2.7 | 2.7 | signal |
| 134 | Leukopenia | 28 | 2.7 | 2.7 | signal |
| 135 | Septic Shock | 24 | 2.6 | 2.6 | signal |
| 136 | Myelodysplastic Syndrome | 8 | 2.6 | 2.6 | signal |
| 137 | Product Packaging Quantity Issue | 6 | 2.6 | 2.6 | signal |
| 138 | Pancreatitis | 29 | 2.6 | 2.6 | signal |
| 139 | Bipolar Disorder | 6 | 2.6 | 2.6 | signal |
| 140 | Liver Function Test Abnormal | 16 | 2.6 | 2.6 | signal |
| 141 | Ventricular Tachycardia | 9 | 2.6 | 2.6 | signal |
| 142 | Hiatus Hernia | 7 | 2.6 | 2.6 | signal |
| 143 | Thrombocytopenia | 60 | 2.6 | 2.6 | signal |
| 144 | Rash Generalised | 14 | 2.5 | 2.5 | signal |
| 145 | Cerebral Haemorrhage | 19 | 2.5 | 2.5 | signal |
| 146 | Status Epilepticus | 6 | 2.5 | 2.5 | signal |
| 147 | Prescribed Overdose | 10 | 2.5 | 2.5 | signal |
| 148 | Agitation | 38 | 2.4 | 2.5 | signal |
| 149 | Renal Disorder | 24 | 2.4 | 2.4 | signal |
| 150 | Erectile Dysfunction | 13 | 2.4 | 2.4 | signal |
| 151 | Accident | 6 | 2.4 | 2.4 | no signal |
| 152 | Type 2 Diabetes Mellitus | 17 | 2.4 | 2.4 | signal |
| 153 | Blood Cholesterol Increased | 23 | 2.3 | 2.3 | signal |
| 154 | Bone Disorder | 9 | 2.3 | 2.3 | signal |
| 155 | Tooth Abscess | 5 | 2.3 | 2.3 | no signal |
| 156 | No Therapeutic Response | 6 | 2.3 | 2.3 | no signal |
| 157 | Pulmonary Arterial Hypertension | 7 | 2.3 | 2.3 | no signal |
| 158 | Gastrointestinal Disorder | 42 | 2.3 | 2.3 | signal |
| 159 | Pain | 286 | 2.2 | 2.3 | signal |
| 160 | Drug Prescribing Error | 9 | 2.2 | 2.2 | signal |
| 161 | Anorexia | 6 | 2.2 | 2.2 | no signal |
| 162 | Pollakiuria | 19 | 2.2 | 2.2 | signal |
| 163 | Gamma-glutamyltransferase Increased | 10 | 2.1 | 2.1 | signal |
| 164 | Angina Pectoris | 13 | 2.1 | 2.1 | signal |
| 165 | Cerebral Infarction | 11 | 2.1 | 2.1 | signal |
| 166 | Obstructive Airways Disorder | 5 | 2.1 | 2.1 | no signal |
| 167 | Coronary Artery Occlusion | 6 | 2.1 | 2.1 | no signal |
| 168 | Caesarean Section | 5 | 2.0 | 2.0 | no signal |
| 169 | Fracture | 8 | 2.0 | 2.0 | no signal |
| 170 | Glaucoma | 8 | 2.0 | 2.0 | no signal |
| 171 | Hyperthyroidism | 6 | 2.0 | 2.0 | no signal |
| 172 | Apathy | 6 | 2.0 | 2.0 | no signal |
| 173 | Toxic Epidermal Necrolysis | 6 | 1.9 | 1.9 | no signal |
| 174 | Poisoning | 5 | 1.9 | 1.9 | no signal |
| 175 | Hypothermia | 4 | 1.9 | 1.9 | no signal |
| 176 | Product Use Complaint | 6 | 1.8 | 1.8 | no signal |
| 177 | Myocardial Infarction | 66 | 1.8 | 1.8 | no signal |
| 178 | Sudden Death | 4 | 1.8 | 1.8 | no signal |
| 179 | Neoplasm Progression | 13 | 1.8 | 1.8 | no signal |
| 180 | Pruritus Generalised | 8 | 1.7 | 1.7 | no signal |
| 181 | Dialysis | 5 | 1.7 | 1.7 | no signal |
| 182 | Upper Limb Fracture | 7 | 1.7 | 1.7 | no signal |
| 183 | Neutropenia | 46 | 1.6 | 1.6 | no signal |
| 184 | Impaired Work Ability | 7 | 1.5 | 1.5 | no signal |
| 185 | Lymphoma | 5 | 1.5 | 1.5 | no signal |
| 186 | Osteonecrosis Of Jaw | 8 | 1.5 | 1.5 | no signal |
| 187 | Nightmare | 11 | 1.5 | 1.5 | no signal |
| 188 | Posterior Reversible Encephalopathy Syndrome | 3 | 1.5 | 1.5 | no signal |
| 189 | Adverse Event | 29 | 1.5 | 1.5 | no signal |
| 190 | Tuberculosis | 4 | 1.5 | 1.5 | no signal |
| 191 | Uveitis | 4 | 1.4 | 1.4 | no signal |
| 192 | Bone Marrow Failure | 6 | 1.4 | 1.4 | no signal |
| 193 | Abnormal Dreams | 8 | 1.4 | 1.4 | no signal |
| 194 | Prostate Cancer | 23 | 1.3 | 1.3 | no signal |
| 195 | Lactic Acidosis | 9 | 1.3 | 1.3 | no signal |
| 196 | Anosmia | 4 | 1.3 | 1.3 | no signal |
| 197 | Toxicity To Various Agents | 45 | 1.3 | 1.3 | no signal |
| 198 | Drug Administration Error | 8 | 1.2 | 1.2 | no signal |
| 199 | Sexual Dysfunction | 3 | 1.2 | 1.2 | no signal |
| 200 | Pancreatic Carcinoma | 7 | 1.1 | 1.1 | no signal |
| 201 | Product Dispensing Error | 5 | 1.1 | 1.1 | no signal |
| 202 | Product Taste Abnormal | 3 | 1.1 | 1.1 | no signal |
| 203 | Palmar-plantar Erythrodysaesthesia Syndrome | 5 | 1.0 | 1.0 | no signal |
| 204 | Drug Dose Omission | 33 | 0.9 | 0.9 | no signal |
| 205 | Extra Dose Administered | 7 | 0.8 | 0.8 | no signal |
| 206 | Myelosuppression | 5 | 0.7 | 0.7 | no signal |
| 207 | Hepatic Cancer | 3 | 0.6 | 0.6 | no signal |
| 208 | Tardive Dyskinesia | 3 | 0.5 | 0.5 | no signal |
| 209 | Renal Cancer | 3 | 0.3 | 0.3 | no signal |